首页|期刊导航|药学研究|化学仿制药复方双层片处方工艺开发一般考虑

化学仿制药复方双层片处方工艺开发一般考虑OA

General considerations for the prescription and process development of chemical generic compound bilayer tablets

中文摘要英文摘要

复方双层片剂可通过联合用药或调整释药速率的方式来增强药效、减轻药物的不良反应、提高患者依从性,是固体制剂领域广受关注的新型制剂.本文结合文献专利、国内外药品相关法律法规和指导原则,对化学仿制药复方双层片在处方筛选和工艺开发过程中的关注点进行总结,包括原料药的粉体学性质、辅料筛选、多规格处方设计、双层压片工艺的开发和批量放大等,以期对化学仿制药复方双层片的开发提供一定的参考.

Compound bilayer tablets have been widely concerned in the development of novel solid formulations because of its advantages including enhancing drug efficacy,reducing side effects and improving patient compliance by combining medications or adjusting the rate of drug release.This review summarized the key points in prescription screening and process development of chemical generic compound bilayer tablets,combining the literature patents,relevant domestic and foreign drug laws and regulations.This included the characteristics of active pharmaceutical ingredients,the selection of ex-cipients,the design of multi-strengths prescription,the development of bilayer process and batch amplification,etc.,in order to provide a reference for generic compound bilayer tablets drug development.

率亚平;赵娜;孙元朋;谢琰;章俊麟

国家药品监督管理局药品审评中心,北京 100076国家药品监督管理局药品审评中心,北京 100076国家药品监督管理局药品审评中心,北京 100076国家药品监督管理局药品审评中心,北京 100076国家药品监督管理局药品审评中心,北京 100076

医药卫生

复方双层片粒径分布处方工艺开发

Compound bilayer tabletsParticle size distributionPrescription and process development

《药学研究》 2026 (2)

182-187,6

10.13506/j.cnki.jpr.2026.02.010

评论